A little background information from our key adviser
Morten Albrechtsen is an MD and BBA (‘HD’ in marketing, CBS). Morten is a seasoned entrepreneur with a strong medical, commercial and financial background. The expertise is gained within a broad range of therapeutic areas and with both drugs and devices. The development expertise includes all stages, pre-clinical, clinical and post-market development, and with various disciplines. The commercial expertise is gained internationally and includes sales through partners, affiliates and direct to patients, hospitals and direct to end-users. It also includes business development with licensing and corporate deals. Previously, Morten has developed and launched new health care products and concepts internationally, e.g. in Nycomed Pharma, now Takeda Pharmaceuticals Ltd. (pain control), Nanovi (brought a new cancer product to the market in Europe and prepared it for US) and Boehringer Ingelheim GmbH (hospital sales, cardiovascular, stroke female health and pain control). Morten has also a strong experience from early clinical development in e.g. Enkam A/S (CNS drug development including medicines for Alzheimer’s disease, Parkinson’s disease and depression), Zleepax ApS (insomnia) and several others.
AI
